NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
- 30 July 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 78 (2) , 468-485
Abstract
Background and Aims: Natural killer (NK) cells are key players in tumor immunosurveillance, and metabolic adaptation manipulates their fate and functional state. The nicotinamide adenine dinucleotide (NAD+) has emerged as a vital factor to link cellular metabolism and signaling transduction. Here, we identified NAD+ metabolism as a central hub to determine the homeostasis and function of NK cells. Approach and Results: NAD+ level was elevated in activated NK cells. NAD+ supplementation not only enhanced cytokine production and cytotoxicity but also improved the proliferation and viability of NK cells. Intriguingly, the salvage pathway was involved in maintaining NAD+ homeostasis in activated NK cells. Genetic ablation or pharmacological blockade of nicotinamide phosphoribosyltransferase (NAMPT), the rate‐limiting enzyme in the NAD+ salvage pathway, markedly destroyed the viability and function of NK cells. Mechanistically, NAD+ salvage dictated the mitochondrial homeostasis and oxidative phosphorylation activity to support the optimal function of NK cells. However, in human HCC tissues, NAMPT expression and NAD+ level were significantly down‐regulated in tumor‐infiltrating NK cells, which negatively correlated with patient survival. And lactate accumulation in the tumor microenvironment was at least partially responsible for the transcriptional repression of NAMPT in NK cells. Further, deficiency of Nampt in NK cells accelerated the growth of HCC and melanoma. Supplementation of the NAD+ precursor nicotinamide mononucleotide (NMN) significantly improved NK antitumor response in both mouse and human cell‐derived xenografts. Conclusions: These findings reveal NAD+ salvage as an essential factor for NK‐cell homeostasis and function, suggesting a potential strategy for invigorating NK cell–based immunotherapy.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFE0126500, 2021YFC2300603)
- National Natural Science Foundation of China (82171805, 81970508, 818300178, 81874178)
This publication has 44 references indexed in Scilit:
- Immunometabolism: Cellular Metabolism Turns Immune RegulatorJournal of Biological Chemistry, 2016
- mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector FunctionThe Journal of Immunology, 2014
- The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cellsNature Immunology, 2014
- Natural killer cell biology: An update and future directionsJournal of Allergy and Clinical Immunology, 2013
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, in Human Cancer CellsJournal of Biological Chemistry, 2013
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor RegressionClinical Cancer Research, 2011
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancerCytotherapy, 2011
- A role for mitochondria in NLRP3 inflammasome activationNature, 2010
- Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent mannerNature Medicine, 2009
- Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell SurvivalCell, 2007